Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: quidditch who wrote (2741)	5/13/1999 10:57:00 PM
From: Art Vandelay AIA	Read Replies (2) of 10280

FYI, I was reading the SEPR 10 K and I was suprised to see that not only is SGP in Phase III trials w/ DCL for allergy, but also Phase II trials for Hives. How many people knew this? Anybody know the market size for hives? Also, I reread David Saks April 20th report from Gruntal. He couldn't of been more positive. The price target is $155 and the EPS numbers for 2001, 2002, and 2003 are still respectively, 2.6, 6.85, 12.10. Also he highlighted that SEPR has patents issued or filed on over 50 chemical compunds covering over $40 BILLION in annual sales. HPPOLK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next